Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data
Status:
Completed
Trial end date:
2007-09-14
Target enrollment:
Participant gender:
Summary
The majority of asthma patients are not well controlled, despite the availability of asthma
medication that could effectively treat the disease. In this study uncontrolled patients who
are steroid-naive or on low dose inhaled corticosteroids will be treated with Seretide
(salmeterol/fluticasone combination, SFC) 50/250 µg twice daily. The asthma control test
(ACT) will be used to detect differences in the level of asthma control during treatment. The
study aims to show a correlation between improvements of ACT und the level of asthma control
which will be reached by the patients.
The aim of the study is to show that most of symptomatic asthma patients can reach 'well
controlled asthma' with SFC. We get information about ACT in daily practice and physicians
are trained to use the asthma control test as a screening tool and for follow up of asthma
management. Correlations are expected between the improvements in ACT, Quality of Life and
asthma control according to the Gaining Optimal Asthma controL (GOAL) criteria.
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Albuterol Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Salmeterol Xinafoate